|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-10-24
|
|
pubmed:abstractText |
In 243 antiretroviral-naive human immunodeficiency-infected patients starting a first-line-protease inhibitor (mainly nelfinavir)-containing therapy, the presence of the polymorphism R57K in the protease at the inception of therapy was independently associated with a higher rate of virological failure.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10199227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10419445,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10448781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10449474,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10708284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-10789605,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11181376,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11316997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11427587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11574912,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11579238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11694829,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-11741159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-12404170,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-8235655,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-8673920,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-8870850,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14576131-9756769
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
pubmed-author:APROCO/COPILOTE Study Group,
pubmed-author:Brun-VézinetFrançoiseF,
pubmed-author:ChêneGenevièveG,
pubmed-author:DaryMartinM,
pubmed-author:DescampsDianeD,
pubmed-author:DrozCecileC,
pubmed-author:FerréVirginieV,
pubmed-author:MasquelierBernardB,
pubmed-author:PerronneChristianC,
pubmed-author:RaffiFrançoisF,
pubmed-author:SpireBrunoB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3623-6
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14576131-Adult,
pubmed-meshheading:14576131-Cohort Studies,
pubmed-meshheading:14576131-Drug Resistance, Viral,
pubmed-meshheading:14576131-Female,
pubmed-meshheading:14576131-HIV Infections,
pubmed-meshheading:14576131-HIV Protease,
pubmed-meshheading:14576131-HIV Protease Inhibitors,
pubmed-meshheading:14576131-Humans,
pubmed-meshheading:14576131-Male,
pubmed-meshheading:14576131-Nelfinavir,
pubmed-meshheading:14576131-Polymorphism, Genetic,
pubmed-meshheading:14576131-Predictive Value of Tests,
pubmed-meshheading:14576131-RNA, Viral,
pubmed-meshheading:14576131-Treatment Failure
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
|
|
pubmed:affiliation |
Laboratoire de Virologie, Hôpital Pellegrin, Bordeaux, France. bernard.masquelier@chu-bordeaux.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
